<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00860899</url>
  </required_header>
  <id_info>
    <org_study_id>1860</org_study_id>
    <secondary_id>1861</secondary_id>
    <nct_id>NCT00860899</nct_id>
  </id_info>
  <brief_title>Postoperative Pain and SIRS After Preoperative Analgesia With Clonidine or Levobupivacaine</brief_title>
  <acronym>PPSAPACL</acronym>
  <official_title>Postoperative Pain and Systemic Inflammatory Stress Response (SIRS) After Preoperative Analgesia With Clonidine or Levobupivacaine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Dubrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Dubrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate hypothesis that preoperative administration of
      epidural clonidine will reduce postoperative pain and systemic inflammatory stress response
      better than epidural levobupivacaine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigations showed that upregulation of prostaglandin E2 and interleukin-6 at central
      sites is an important component of surgery induced inflammatory response in patients.
      Postoperative period is associated with an increased production of cytokines, which augment
      pain sensitivity. With adequate perioperative pain control it is possible to control central
      and peripheral inflammatory response to surgery, and influence on patient outcomes. Use of
      analgetics before the pain stimulus (preventive analgesia) prevent development of
      neuroplastic changes in central nervous system, and reduces pain. Clonidine is an
      alpha2-adrenergic agonist with sedative, analgesic and hemodynamic properties. It inhibits
      transmission of nociceptive stimuli in the dorsal horn of the spinal cord, acting on the
      inhibitory descending pathways. According to recent experimental investigations clonidine
      lowers proinflammatory cytokine level, and prevents hypersensitization acting through
      adrenoreceptors alpha-2A.

      Levobupivacaine is a long-acting local anesthetic, S-enantiomer of bupivacaine, with
      identical anesthetic potency. When administered intraperitoneally or by local infiltration of
      operation site, levobupivacaine produced analgesia and reduction of proinflammatory
      cytokines. Investigations of epidural and intrathecal levobupivacaine provide evidence for
      improved postoperative analgesia with reduced analgesic consumption. But, it remains unknown
      if that analgesia is sufficient enough to blockade inflammatory stress response during
      perioperative time.We want to investigate and compare analgesic and immunomodulation efficacy
      of this two frequently used analgesics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain level</measure>
    <time_frame>1 h before surgery, 1 h after start of the surgery, 1 h , 6 h , 12 h and 24 h after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>systemic inflammatory stress response</measure>
    <time_frame>1 hour before surgery, 1 hour after start of the surgery, 1 h , 6 h , 12 h and 24 h after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Analgesia</condition>
  <condition>Pain</condition>
  <condition>Systemic Inflammatory Stress Response</condition>
  <arm_group>
    <arm_group_label>clonidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clonidine is an alpha2-adrenergic agonist with sedative, analgesic and hemodynamic properties. It inhibits transmission of nociceptive stimuli in the dorsal horn of the spinal cord, acting on the inhibitory descending pathways.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levobupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Levobupivacaine is long-acting local anesthetic, S-enantiomer of bupivacaine, with identical anesthetic potency.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>clonidine, levobupivacaine</intervention_name>
    <description>One hour prior to skin incision, on epidural catheter, patients received 5 µg/kg of clonidine [Catapres®, Boehringer Ingelheim, Germany], 7 mL of 0.25% levobupivacaine [Chirocaine®, Abbott S.p.A., Italy] or 7 mL of saline.The study was designed to compare clonidine and levobupivacaine, and than both with the control group, in order to asses their analgesic and immunomodulation efficacy.</description>
    <arm_group_label>clonidine</arm_group_label>
    <arm_group_label>levobupivacaine</arm_group_label>
    <other_name>clonidine [Catapres®, Boehringer Ingelheim, Germany]</other_name>
    <other_name>levobupivacaine [Chirocaine®, Abbott S.p.A., Italy]</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  colorectal resection surgery patients

          -  preoperative risk of anesthesia and operation, ASA (American Society of
             Anesthesiologists) physical status I or II

        Exclusion Criteria:

          -  diabetes mellitus

          -  renal insufficiency

          -  liver insufficiency

          -  autoimmune disease

          -  corticosteroid and immunosuppressive use

          -  operation time exceeding six hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>42 Years</minimum_age>
    <maximum_age>77 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jasminka Persec, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesiology, Resuscitation and Intensive Care Medicine Clinic, University Hospital Dubrava</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zoran Persec, MD Msc</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Urology, University Hospital Dubrava</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ino Husedzinovic, Prof. MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>Anesthesiology, Resuscitation and Intensive Care Medicine Clinic, University Hospital Dubrava</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Dubrava</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>1. Buvanendran A, Kroin JS, Berger RA, Hallab NJ, Saha C et al.Anesthesiology 104(3):403-410, 2006. 2. Katz J. Curr Opin Anaesthesiol 15(4):435-441, 2002. 3. Carr DB. Anesthesiology 85(6): 1498-1499, 1996. 4. Lavand'homme PM, Eisenach JC. Pain 105(1-2):247-254, 2003. 5. Nader ND, Ignatowski TA, Kurek CJ, Knight PR, Spengler RN. Anesth Analg 93(2):363-369, 2001. 6. Wu CT, Jao SW, Borel CO, Yeh CC, Li CY, Lu CH et al. Anesth Analg 99(2):502-509, 2004. 7. Novak-Jankovic V, Bovill JG, Ihan A, Osredkar J. Eur J Anaesthesiology 17(1):50-56, 2000. 8. Kim MH, Hahn TH. Anesth Analg 90(6):1441-1444, 2000. 9. Louizos AA, Hadzilia SJ, Leandros E, Kouroukli IK, Georgiou LG et al. Surg Endosc 19(11):1503-1506, 2005. 10. Meisner M, Brunkhorst FM, Reith HB, Schmidt J, Lestin HG et al. Clin Chem Lab Med 38(10):989-995, 2000. 11. Naeini AE, Montazerolghaem S. Saudi Med J 27(3):422-424, 2006. 12. Sarbinowski R, Arvidsson S, Tylman M, Oresland T, Bengtsson A. Acta Anaesthesiol Scand 49(2):191-196, 2005.</citation>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 10, 2009</study_first_submitted>
  <study_first_submitted_qc>March 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2009</study_first_posted>
  <last_update_submitted>November 16, 2011</last_update_submitted>
  <last_update_submitted_qc>November 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Dubrava</investigator_affiliation>
    <investigator_full_name>Jasminka Persec, MD, PhD</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>clonidine</keyword>
  <keyword>levobupivacaine</keyword>
  <keyword>preoperative analgesia</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>systemic inflammatory stress response</keyword>
  <keyword>epidural analgesia</keyword>
  <keyword>Anesthetics, Local</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

